Cancer treatment methods using selected antibodies to aminophospholipids
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 24, 2009
Grant Date -
Jun 23, 2005
app pub date -
Aug 15, 2003
filing date -
Jul 15, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Also disclosed are advantageous antibody, immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully